These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 24606102)

  • 1. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
    Irani M; Minkoff H; Seifer DB; Merhi Z
    J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
    Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S
    Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
    Merhi Z; Irani M; Doswell AD; Ambroggio J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.
    Garg D; Grazi R; Lambert-Messerlian GM; Merhi Z
    J Assist Reprod Genet; 2017 Nov; 34(11):1507-1513. PubMed ID: 28825156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review.
    Irani M; Merhi Z
    Fertil Steril; 2014 Aug; 102(2):460-468.e3. PubMed ID: 24933120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
    Pearce K; Gleeson K; Tremellen K
    Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin D on pregnancy in women with polycystic ovary syndrome: retrospective and prospective studies.
    Piao C; Li J; Liang C; Zhang J; Li X; Zhao Z; Wang K
    Reprod Biomed Online; 2024 Aug; 49(2):103909. PubMed ID: 38776748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome.
    Wong HYQ; Li HWR; Lam KSL; Tam S; Shek CC; Lee CYV; Yeung WSB; Ho PC; Ng EHY
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):634-641. PubMed ID: 30019416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
    Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.